NEW YORK, Oct. 22, 2022 (GLOBE NEWSWIRE) — Pomerantz LLP announces that a class action lawsuit has been filed against Humanigen, Inc. (“Humanigen” or the
NEW YORK, Oct. 22, 2022 (GLOBE NEWSWIRE) — Pomerantz LLP Investigating Claims on Behalf of Investors in Sema4 Holdings Corp. (“Sema4” or the “Company”) (NASDAQ:
NEW YORK, Oct. 22, 2022 (GLOBE NEWSWIRE) — Pomerantz LLP Investigating Claims on Behalf of Investors of TuSimple Holdings Inc. (“TuSimple” or the “Company”) TSP.
NEW YORK, Oct. 22, 2022 (GLOBE NEWSWIRE) — Pomerantz LLP is investigating claims on behalf of investors of TuSimple Holdings Inc. (“TuSimple” or the “Company”)
NEW YORK, Oct. 22, 2022 (GLOBE NEWSWIRE) — Pomerantz LLP is investigating claims on behalf of investors from Twitter, Inc. (“Twitter” or the “Company”) TWTR.
NEW YORK, Oct. 22, 2022 (GLOBE NEWSWIRE) — Pomerantz LLP is investigating claims on behalf of investors from Twitter, Inc. (“Twitter” or the “Company”) (NYSE:
NEW YORK, Oct. 22, 2022 (GLOBE NEWSWIRE) — Pomerantz LLP Investigating Claims on Behalf of Investors of Medtronic Plc (“Medtronic” or the “Company”) MDT. Those
NEW YORK, Oct. 22, 2022 (GLOBE NEWSWIRE) — Pomerantz LLP is investigating claims on behalf of investors in Medtronic Plc (“Medtronic” or the “Company”) (NYSE:
SAN DIEGO, Oct. 22, 2022 (GLOBE NEWSWIRE) — The law firm of Robbins Geller Rudman & Dowd LLP announces that buyers or acquirers of Block,
SAN DIEGO, Oct. 22, 2022 (GLOBE NEWSWIRE) — The law firm of Robbins Geller Rudman & Dowd LLP announces that buyers or acquirers of Block,
NEW YORK, Oct. 22, 2022 (GLOBE NEWSWIRE) — Pomerantz LLP is investigating claims on behalf of investors of Supernus Pharmaceuticals, Inc. (“Supernus” or the “Company”)
NEW YORK, Oct. 22, 2022 (GLOBE NEWSWIRE) — Pomerantz LLP is investigating claims on behalf of investors in Supernus Pharmaceuticals, Inc. (“Supernus” or the “Company”)
NEW YORK, Oct. 22, 2022 (GLOBE NEWSWIRE) — Pomerantz LLP announces that a class action lawsuit has been filed against Humanigen, Inc. (“Humanigen” or the
NEW YORK, Oct. 22, 2022 (GLOBE NEWSWIRE) — Pomerantz LLP Investigating Claims on Behalf of Investors in Sema4 Holdings Corp. (“Sema4” or the “Company”) (NASDAQ:
NEW YORK, Oct. 22, 2022 (GLOBE NEWSWIRE) — Pomerantz LLP Investigating Claims on Behalf of Investors of TuSimple Holdings Inc. (“TuSimple” or the “Company”) TSP.
NEW YORK, Oct. 22, 2022 (GLOBE NEWSWIRE) — Pomerantz LLP is investigating claims on behalf of investors of TuSimple Holdings Inc. (“TuSimple” or the “Company”)
NEW YORK, Oct. 22, 2022 (GLOBE NEWSWIRE) — Pomerantz LLP is investigating claims on behalf of investors from Twitter, Inc. (“Twitter” or the “Company”) TWTR.
NEW YORK, Oct. 22, 2022 (GLOBE NEWSWIRE) — Pomerantz LLP is investigating claims on behalf of investors from Twitter, Inc. (“Twitter” or the “Company”) (NYSE:
NEW YORK, Oct. 22, 2022 (GLOBE NEWSWIRE) — Pomerantz LLP Investigating Claims on Behalf of Investors of Medtronic Plc (“Medtronic” or the “Company”) MDT. Those
NEW YORK, Oct. 22, 2022 (GLOBE NEWSWIRE) — Pomerantz LLP is investigating claims on behalf of investors in Medtronic Plc (“Medtronic” or the “Company”) (NYSE:
SAN DIEGO, Oct. 22, 2022 (GLOBE NEWSWIRE) — The law firm of Robbins Geller Rudman & Dowd LLP announces that buyers or acquirers of Block,
SAN DIEGO, Oct. 22, 2022 (GLOBE NEWSWIRE) — The law firm of Robbins Geller Rudman & Dowd LLP announces that buyers or acquirers of Block,
NEW YORK, Oct. 22, 2022 (GLOBE NEWSWIRE) — Pomerantz LLP is investigating claims on behalf of investors of Supernus Pharmaceuticals, Inc. (“Supernus” or the “Company”)
NEW YORK, Oct. 22, 2022 (GLOBE NEWSWIRE) — Pomerantz LLP is investigating claims on behalf of investors in Supernus Pharmaceuticals, Inc. (“Supernus” or the “Company”)
